Market Overview

Oppenheimer Reiterates Perform Rating on Gentiva Health Services on FY2013 Outlook

Related GTIV
Top 4 Small-Cap Stocks In The Home Health Care Industry With The Highest Gross Margin
Benzinga's M&A Chatter for Thursday October 9, 2014

In a report published Wednesday, Oppenheimer analyst Michael Wiederhorn reiterated a Perform rating on Gentiva Health Services (NASDAQ: GTIV).

In the report, Wiederhorn noted, “Gentiva issued its FY2013 outlook, which includes EPS of $0.90-$1.10, compared to our estimate of $1.15 and Street consensus of $1.26. The guidance includes a $0.60 impact from the Medicare sequestration, well above the impact included in our estimate. As a result of the outlook, we are reducing our FY2013-14 estimates to $0.98 and $0.99, from $1.15 and $1.17, respectively.”

Gentiva Health Services closed on Tuesday at $12.62.

Latest Ratings for GTIV

Aug 2014Credit SuisseMaintainsUnderperform
Jul 2014Deutsche BankMaintainsHold
Jun 2014CRT CapitalDowngradesBuyFair Value

View More Analyst Ratings for GTIV
View the Latest Analyst Ratings

Posted-In: OppenheimerAnalyst Color Reiteration Analyst Ratings


Related Articles (GTIV)

View Comments and Join the Discussion!